Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Truscreen for InfoPages here.
Truscreen - Latest News [Page 1]
Truscreen reports 523% sales growth for first half year
Tuesday, 16 October 2018, 10:28 am | Truscreen
• Sales for the six months ending 30 September 2018 tops NZD $1,406,932 (unaudited) • 522.8% increase on the corresponding period last year (NZD $225,896) • Gross margin increasing as in-house manufacturing lowers unit costs Cervical cancer screening ... More >>
Truscreen Announces Capital Raising
Wednesday, 22 March 2017, 10:10 am | Truscreen
Cervical cancer technology company, TruScreen Limited (NZAX:TRU) has undertaken a $4.09 million share placement to institutional and other select investors as it looks to strengthen its balance sheet and fund commercial growth. In addition to the placement, ... More >>
Truscreen Gains Access to India Market
Tuesday, 7 March 2017, 10:36 am | Truscreen
Cervical cancer technology company, TruScreen Limited (NZAX:TRU), has entered into commercial agreements with Khandelwal Laboratories Pvt Limited ( K.Lab) for the purpose of providing TruScreen with access to the Indian market. India is the world’s largest ... More >>
Truscreen Update – Europe And Other Markets
Monday, 6 March 2017, 12:21 pm | Truscreen
Cervical cancer technology company, TruScreen Limited (NZAX: TRU), the manufacturer of real time cervical cancer screening technology, advises that it has entered into distribution agreements for the sale of its TruScreen device in multiple new markets. ... More >>
Truscreen Preliminary Unaudited Financial Results
Tuesday, 14 June 2016, 11:37 am | Truscreen
TruScreen (NZX: TRU), the world’s only CE certified manufacturer of an electro-light tissue differentiating device for the detection of cervical cancer, today released its preliminary unaudited financial results for the year ended 31 March 2016. More >>
Truscreen Selected For Major Chinese Screening Programme
Tuesday, 31 May 2016, 11:11 am | Truscreen
Cancer technology company TruScreen Limited (NZAX: TRU) advises that its technology has been selected for use in a major cervical cancer screening programme in North China. More >>
TRUSCREEN COMMENCES EXPORT OF SECOND GENERATION DEVICE
Monday, 2 May 2016, 12:13 pm | Truscreen
Cancer technology company TruScreen Limited (NZAX: TRU) advises that supply and export of its second generation cervical cancer screening device, known as TruScreen Ultra, has commenced with initial shipments to Latin America (Mexico) and the Middle East ... More >>
Certification for Truscreen 2nd Generation Device
Friday, 15 April 2016, 2:40 pm | Truscreen
Cancer technology company, TruScreen Limited (NZAX:TRU) advises that its second generation cervical cancer screening device, known as “TruScreen Ultra”, is now ready for commercial launch in select markets following receipt of CE Mark certification. This ... More >>
TruScreen Share Purchase Plan Exceeds Target
Wednesday, 1 July 2015, 11:14 am | Truscreen
Kiwi cancer diagnostic company TruScreen (TRU) has surpassed its target of $1million of capital to be raised via a Share Purchase Plan (SPP) for New Zealand resident shareholders. More >>
Chinese Approval Opens Huge Market to Kiwi Tech Company
Thursday, 30 April 2015, 1:01 pm | Truscreen
TruScreen Limited (NZAX: TRU), a New Zealand company with a unique real time cervical cancer screening technology now has open access to a potential NZD $1 billion per annum market after receiving Chinese Food And Drug Administration (CFDA) approval ... More >>
